RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$6.49
+0.21 (+3.34%)
Open$6.50
Previous Close$6.28
Day High$6.65
Day Low$6.28
52W High$39.19
52W Low$27.12
Volume—
Avg Volume402.6K
Market Cap168.76M
P/E Ratio54.03
EPS$0.58
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+526.5% upside
Current
$6.49
$6.49
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 132.58M | 132.93M | 135.85M |
| Net Income | 3.35M | 3.48M | 3.56M |
| Profit Margin | 2.5% | 2.6% | 2.6% |
| EBITDA | 5.30M | 5.52M | 5.23M |
| Free Cash Flow | 2.64M | 2.68M | 1.65M |
| Rev Growth | +18.2% | -1.8% | +9.5% |
| Debt/Equity | 0.78 | 0.86 | 0.78 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |